Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
The Oncologist|May 25, 2012
A randomized, phase II trial of standard triweekly compared with dose-dense biweekly capecitabine plus oxaliplatin plus bevacizumab as first-line treatment for metastatic colorectal cancer: XELOX-A-DVS (dense versus standard)Herbert Hurwitz, Edith P Mitchell, Thomas Cartwright, et al.
Hepatology (Baltimore, Md.)|April 30, 2003
Recombinant human interleukin-11 improves thrombocytopenia in patients with cirrhosisReem Ghalib, Cheryl Levine, Manal Hassan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2010
Phase II trial of combined modality therapy with myeloid growth factor support in patients with locally advanced non-small cell lung cancerRogerio Lilenbaum, Michael Samuels, Michele Taffaro-Neskey, et al.
Journal of Cancer Research and Clinical Oncology|May 28, 2008
A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinomaKimberly B Higginbotham, Richard Lozano, Thomas Brown, et al.
Breast Disease|May 31, 2022
ROS1 altered breast cancers - a distinctive molecular subtype of PR- metastatic breast cancers: Expanding the scope of targeted therapeuticsKritika Krishnamurthy, Arunima Deb, Sarah Alghamdi, et al.
Pathology, Research and Practice|March 3, 2022
The mutational landscape of upper gastrointestinal adenocarcinomas- A study of similarities and differencesKritika Krishnamurthy, Sophia Navajas Urioste, Mike Cusnir, et al.
The American Journal of Dermatopathology|April 16, 2021
Analysis of Genetic Alterations in Cutaneous Malignant Melanomas Unveils Unique Loco-Regional Variations and Novel Predictors of Metastatic PotentialKritika Krishnamurthy, Sophia N Urioste, Mike Cusnir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinomaYehuda Z Patt, Manal M Hassan, Richard D Lozano, et al.
Hepatology (Baltimore, Md.)|October 24, 2002
Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitusManal M Hassan, Lu-Yu Hwang, Chiq J Hatten, et al.
The American Journal of Gastroenterology|February 28, 2007
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control studyYasser H Shaib, Hashem B El-Serag, Ajay K Nooka, et al.
Pageof 5